Lupin inks BTA to carve out two API manufacturing sites

17 Oct 2023 Evaluate

Lupin has entered into a Business Transfer Agreement (BTA) with Lupin Manufacturing Solutions (LMSL), wholly owned subsidiary of the Company, to carve out two Active Pharmaceutical Ingredients (API) manufacturing sites situated at Dabhasa and Visakhapatnam and select R&D operations, including fermentation, at Lupin Research Park, Pune. Earlier, the company had received approval from board of directors to enter into a business transfer agreement.

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.


Lupin Share Price

2083.30 -28.70 (-1.36%)
01-Jan-2026 10:47 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1710.85
Dr. Reddys Lab 1253.65
Cipla 1503.15
Zydus Lifesciences 910.00
Lupin 2083.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×